169 related articles for article (PubMed ID: 29528920)
1. Occult Gynecologic Cancer in Women Undergoing Hysterectomy or Myomectomy for Benign Indications.
Desai VB; Wright JD; Schwartz PE; Jorgensen EM; Fan L; Litkouhi B; Lin H; Gross CP; Xu X
Obstet Gynecol; 2018 Apr; 131(4):642-651. PubMed ID: 29528920
[TBL] [Abstract][Full Text] [Related]
2. Uterine weight and complications after abdominal, laparoscopic, and vaginal hysterectomy.
Louie M; Strassle PD; Moulder JK; Dizon AM; Schiff LD; Carey ET
Am J Obstet Gynecol; 2018 Nov; 219(5):480.e1-480.e8. PubMed ID: 29959931
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 30-day Complication Rates between Laparoscopic Myomectomy and Total Laparoscopic Hysterectomy for the Treatment of Uterine Leiomyoma in Women Older Than Age 40.
Sheyn D; Bretschnieder CE; Mahajan ST; El-Nashar S; Billow M; Ninivaggio CS
J Minim Invasive Gynecol; 2019; 26(6):1076-1082. PubMed ID: 30385429
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of undiagnosed uterine leiomyosarcoma in women undergoing hysterectomy or myomectomy for benign indications.
Lange S; Pluchino N; Fehlmann A; Marci R; Boukrid M; Jazia IB; Petignat P; Dubuisson J
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():239-244. PubMed ID: 28743407
[TBL] [Abstract][Full Text] [Related]
5. Risk of Undetected Cancer at the Time of Laparoscopic Supracervical Hysterectomy and Laparoscopic Myomectomy: Implications for the Use of Power Morcellation.
Perkins RB; Handal-Orefice R; Hanchate AD; Lin M; Paasche-Orlow MK
Womens Health Issues; 2016; 26(1):21-6. PubMed ID: 26701205
[TBL] [Abstract][Full Text] [Related]
6. Association Between Body Mass Index, Uterine Size, and Operative Morbidity in Women Undergoing Minimally Invasive Hysterectomy.
Shah DK; Van Voorhis BJ; Vitonis AF; Missmer SA
J Minim Invasive Gynecol; 2016; 23(7):1113-1122. PubMed ID: 27523922
[TBL] [Abstract][Full Text] [Related]
7. Association Between Power Morcellation and Mortality in Women With Unexpected Uterine Cancer Undergoing Hysterectomy or Myomectomy.
Xu X; Lin H; Wright JD; Gross CP; Boscoe FP; Hutchison LM; Schwartz PE; Desai VB
J Clin Oncol; 2019 Dec; 37(35):3412-3424. PubMed ID: 31518176
[TBL] [Abstract][Full Text] [Related]
8. Unanticipated Uterine and Cervical Malignancy in Women Undergoing Hysterectomy for Uterovaginal Prolapse.
Andiman SE; Bui AH; Hardart A; Xu X
Female Pelvic Med Reconstr Surg; 2021 Jun; 27(6):e549-e554. PubMed ID: 33208657
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Malignancy and Myoma Variants at Surgery for Presumed Benign Symptomatic Myomas.
Damasco MR; Chan PK; Slonim M; Ang WC; Healey MG
J Minim Invasive Gynecol; 2017; 24(4):659-664. PubMed ID: 28216458
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Surgical Outcomes After Total Laparoscopic Hysterectomy or Total Vaginal Hysterectomy for Large Uteri.
Sailofsky S; Darin C; Alfahmy A; Sheyn D
Obstet Gynecol; 2021 Mar; 137(3):445-453. PubMed ID: 33543889
[TBL] [Abstract][Full Text] [Related]
11. Hospital variation in responses to safety warnings about power morcellation in hysterectomy.
Xu X; Desai VB; Wright JD; Lin H; Schwartz PE; Gross CP
Am J Obstet Gynecol; 2021 Jun; 224(6):589.e1-589.e13. PubMed ID: 33359176
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Hysterectomy Route, Resource Use, and Outcomes: Change After Power Morcellation Warning.
Desai VB; Wright JD; Lin H; Gross CP; Sallah YH; Schwartz PE; Xu X
Obstet Gynecol; 2019 Aug; 134(2):227-238. PubMed ID: 31348209
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
[TBL] [Abstract][Full Text] [Related]
14. Morcellation and the Incidence of Occult Uterine Malignancy: A Dual-Institution Review.
Picerno TM; Wasson MN; Gonzalez Rios AR; Zuber MJ; Taylor NP; Hoffman MK; Borowsky ME
Int J Gynecol Cancer; 2016 Jan; 26(1):149-55. PubMed ID: 26332395
[TBL] [Abstract][Full Text] [Related]
15. Practice Patterns and Complications of Benign Hysterectomy Following the FDA Statement Warning Against the Use of Power Morcellation.
Multinu F; Casarin J; Hanson KT; Angioni S; Mariani A; Habermann EB; Laughlin-Tommaso SK
JAMA Surg; 2018 Jun; 153(6):e180141. PubMed ID: 29641835
[TBL] [Abstract][Full Text] [Related]
16. The impact of surgeon volume on perioperative adverse events in women undergoing minimally invasive hysterectomy for the large uterus.
Bretschneider CE; Frazzini Padilla P; Das D; Jelovsek JE; Unger CA
Am J Obstet Gynecol; 2018 Nov; 219(5):490.e1-490.e8. PubMed ID: 30222939
[TBL] [Abstract][Full Text] [Related]
17. The incidence of unexpected gynaecological malignancies in hysterectomies carried out for benign indications.
Yildiz G; Mat E; Yildiz P; Gundogdu EC; Basol G; Kurt D; Kale A
J Obstet Gynaecol; 2021 Feb; 41(2):298-304. PubMed ID: 33448228
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors of early postoperative small bowel obstruction in patients undergoing hysterectomy for benign indications.
Sheyn D; Bretschneider CE; Mahajan ST; Ridgeway B; Davenport A; Pollard R
Am J Obstet Gynecol; 2019 Mar; 220(3):251.e1-251.e9. PubMed ID: 30471258
[TBL] [Abstract][Full Text] [Related]
19. Risk of Occult Uterine Sarcoma in Women Undergoing Hysterectomy for Benign Indications.
Kho KA; Lin K; Hechanova M; Richardson DL
Obstet Gynecol; 2016 Mar; 127(3):468-473. PubMed ID: 26855091
[TBL] [Abstract][Full Text] [Related]
20. Removal of normal ovaries in women under age 51 at the time of hysterectomy.
Karp NE; Fenner DE; Burgunder-Zdravkovski L; Morgan DM
Am J Obstet Gynecol; 2015 Nov; 213(5):716.e1-6. PubMed ID: 26032038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
